TRIM63 and COVID-19: Taken together, there is evidence suggestive of molecular mimicry between the immunologically important Spike protein fusion peptide and the muscle proteins TRIM63 and CCDC63 alongside associations with muscular symptoms post-COVID-19 and COVID-19 severity.